申请人:Li An-Hu
公开号:US20120329826A1
公开(公告)日:2012-12-27
Compounds of Formula I, as shown below and defined herein: pharmaceutically acceptable salts, synthesis, intermediates, formulations, and methods of disease treatment therewith, including cancers mediated at least in part by RON and/or MET.
公式I的化合物,如下所示并在此定义:药物可接受的盐,合成,中间体,制剂以及使用其进行疾病治疗的方法,包括至少部分由RON和/或MET介导的癌症治疗。